Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Ahn, Soo Min [1 ]
Oh, Ji Seon [2 ]
Heo, Hyun Mi [3 ]
Hong, Seokchan [3 ]
Lee, Chang-Keun [3 ]
Yoo, Bin [1 ]
Kim, Yong-Gil [3 ]
机构：
[1] ASAN Med Ctr, Seoul, South Korea
[2] Asan Med Ctr, Ulsan, South Korea
[3] Asan Med Ctr, Seoul, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0836
引用
收藏
页码：1728 / 1730
页数：3
相关论文
共 50 条
  • [31] Bridging from Intravenous to Subcutaneous Formulation of Tocilizumab for Optimal Dose Regimens in Polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Gibiansky, Leonid
    Gibiansky, Ekaterina
    Frey, Nicolas
    Mallalieu, Navita L.
    Petry, Claire
    Charoin, Jean-Eric
    Douglass, Wendy
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S132 - S132
  • [32] Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab
    Asai, Shuji
    Takahashi, Nobunori
    Hayashi, Masatoshi
    Hanabayashi, Masahiro
    Kanayama, Yasuhide
    Takemoto, Toki
    Yabe, Yuichiro
    Shioura, Tomone
    Ishikawa, Hisato
    Yoshioka, Yutaka
    Kato, Takefumi
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Hattori, Yosuke
    Kobayakawa, Tomonori
    Ando, Masahiko
    Kuwatsuka, Yachiyo
    Matsumoto, Takuya
    Asai, Nobuyuki
    Sobue, Yasumori
    Nishiume, Tsuyoshi
    Suzuki, Mochihito
    Ishiguro, Naoki
    Kojima, Toshihisa
    JOINT BONE SPINE, 2020, 87 (06) : 596 - 602
  • [33] Bridging from Intravenous to Subcutaneous Formulation of Tocilizumab for Optimal Dose Regimens in Systemic Juvenile Idiopathic Arthritis (sJIA)
    Gibiansky, Leonid
    Gibiansky, Ekaterina
    Frey, Nicolas
    Mallalieu, Navita L.
    Petry, Claire
    Charoin, Jean-Eric
    Bao, Mm
    Mela, Christopher
    Douglass, Wendy
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S60 - S60
  • [34] SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS; A HIGH NUMBER OF PATIENTS ACHIEVE DOPPLER REMISSION AFTER 24 WEEKS
    Hammer, H. B.
    Hansen, I. M. J.
    Jarvinen, P.
    Leirisalo-Repo, M.
    Ziegelasch, M.
    Agular, B.
    Terslev, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 319 - 319
  • [35] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Nicolette T. Morris
    Jenny Brook
    Ami Ben-Artzi
    William Martin
    Tanaz A. Kermani
    Lynette Avedikian-Tatosyan
    George Karpouzas
    Himakar Nagam
    Geraldine Navarro
    Soo Choi
    Mihaela B. Taylor
    David Elashoff
    Gurjit S. Kaeley
    Veena K. Ranganath
    Clinical Rheumatology, 2021, 40 : 5055 - 5065
  • [36] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Morris, Nicolette T.
    Brook, Jenny
    Ben-Artzi, Ami
    Martin, William
    Kermani, Tanaz A.
    Avedikian-Tatosyan, Lynette
    Karpouzas, George
    Nagam, Himakar
    Navarro, Geraldine
    Choi, Soo
    Taylor, Mihaela B.
    Elashoff, David
    Kaeley, Gurjit S.
    Ranganath, Veena K.
    CLINICAL RHEUMATOLOGY, 2021, 40 (12) : 5055 - 5065
  • [37] Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    McLaughlin, Maeve
    Oestoer's, Andrew
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 429 - 437
  • [38] Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
    Negoescu A.F.
    Östör A.J.K.
    Rheumatology and Therapy, 2015, 2 (1) : 17 - 31
  • [39] Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis
    Ogata, Atsushi
    Kato, Yasuhiro
    Higa, Shinji
    Maeda, Keiji
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (06) : 639 - 648
  • [40] A MULTICENTRE AUDIT OF DISEASE ACTIVITY AND COMPLICATIONS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS TOCILIZUMAB
    Boyce, Bashaar
    James, Benjamin
    Cates, Matthew
    RHEUMATOLOGY, 2017, 56 : 138 - 138
12345